In Conte v. Wyeth, a California appellate court held that the manufacturer of a brand name drug could potentially be held liable for an injury allegedly caused by the generic version of the drug.
Today, the California Supreme Court refused to review the appellate court decision. Although we can’t yet locate the order on the California Supreme Court website, counsel in the case received the following e-mail notice:
CONTE v. WYETH, INC.
Case: S169116, Supreme Court of California
Date (YYYY-MM-DD): 2009-01-21
Event Description: Petitions for review denied
Baxter, J., is of the opinion respondent’s petition should be granted.